In this Webcast, Karl Siegling discusses the company’s performance for the September 2018 quarter, including a more detailed review of two current positions in the portfolio, ARQ Group (ASX:ARQ) and Teva Pharmaceutical Industries (NYSE:TEVA). He then concludes with an updated outlook for the fund, and a brief overview of the upcoming Cadence Opportunities Fund […]
In this Webcast, Karl Siegling discusses the company’s expected record profit for 2018, stocks that performed well for the year and details of the final dividend. He briefly discusses global growth, the company’s outlook over the coming year and then concludes by introducing the upcoming Initial Public Offering (IPO) – Cadence Opportunities Fund.
In this video Karl Siegling, Alan Crozier and Chris Garrard, portfolio managers of Cadence Capital Limited, give an update on the Company’s performance, discussed some of the Company’s stock holdings and give a brief outlook for 2018.